ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
123.046,85
0,20%
S&P 500
5.842,63
1,12%
US Dollar vs BRL
5,7826
-1,77%
Bitcoin
90.787,21
0,17%
Brent Oil
69,525
0,38%
As Melhores Corretoras Online
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Nuvectis Pharma Inc (NVCT)

  7. Nuvectis Pharma Inc (NVCT) Notícias

NVCT

Nuvectis Pharma (NVCT)

Nuvectis Pharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVCT
DataHoraFonteTítuloCódigoCompanhia
27/02/202512:43Business WireMarket News Alert: Nuvectis Pharma Receives $18 Price Target and Buy Rating from Lucid Capital MarketsNASDAQ:NVCTNuvectis Pharma Inc
25/02/202518:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:NVCTNuvectis Pharma Inc
25/02/202511:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVCTNuvectis Pharma Inc
06/02/202508:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NVCTNuvectis Pharma Inc
03/01/202520:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVCTNuvectis Pharma Inc
03/01/202519:00Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVCTNuvectis Pharma Inc
05/11/202410:31Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVCTNuvectis Pharma Inc
28/10/202409:21Business WirePESG Releases Market Update: Nuvectis Pharma Shows Promising Synergy for NXP900 in Recent Presentations; Growing Anticipation for Upcoming NXP800 Data UpdateNASDAQ:NVCTNuvectis Pharma Inc
16/09/202408:15Business WirePESG Releases Report on Nuvectis Pharma: With Summit Therapeutics Threatening to Dethrone Merck's Keytruda, Nuvectis' NXP900 is One to WatchNASDAQ:NVCTNuvectis Pharma Inc
27/06/202309:46Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NVCTNuvectis Pharma Inc
16/06/202317:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NVCTNuvectis Pharma Inc
10/05/202317:31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NVCTNuvectis Pharma Inc
28/04/202317:08Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:NVCTNuvectis Pharma Inc
03/04/202309:16Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NVCTNuvectis Pharma Inc
30/03/202307:09Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:NVCTNuvectis Pharma Inc
27/03/202309:31Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:NVCTNuvectis Pharma Inc
17/03/202317:32Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:NVCTNuvectis Pharma Inc
08/03/202319:32Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NVCTNuvectis Pharma Inc
09/01/202312:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NVCTNuvectis Pharma Inc
14/09/202207:15TipRanksH.C. Wainwright Reaffirms Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
15/08/202210:10Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:NVCTNuvectis Pharma Inc
10/08/202217:31Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:NVCTNuvectis Pharma Inc
05/08/202211:45TipRanksH.C. Wainwright Sticks to Its Buy Rating for Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
21/06/202210:56TipRanksNuvectis Pharma (NVCT) Receives a Buy from H.C. WainwrightNASDAQ:NVCTNuvectis Pharma Inc
11/04/202213:25TipRanksAnalysts Offer Insights on Healthcare Companies: Cellectis SA (CLLS) and Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
05/04/202207:16TipRanksH.C. Wainwright Keeps Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
28/03/202218:23Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:NVCTNuvectis Pharma Inc
24/03/202214:16Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NVCTNuvectis Pharma Inc
24/03/202209:11Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NVCTNuvectis Pharma Inc
22/03/202211:55TipRanksH.C. Wainwright Reiterates Their Buy Rating on Nuvectis Pharma (NVCT)NASDAQ:NVCTNuvectis Pharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:NVCT

Seu Histórico Recente

ASX
PICNB
Perpetual Equity Investm...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios